Fraser Murray is the Chief Executive Officer and Investor Director at Pheno Therapeutics Ltd based in Edinburgh. With a background in neuroscience and immunology, Fraser has co-founded and worked in various roles in companies focused on developing innovative therapeutics for neurodegenerative diseases and autoimmune diseases. Currently involved in leading and supporting different scientific programs, Fraser's expertise in phenotypic screening and stem cell technology has contributed to the advancement of research in the life sciences industry.
Sign up to view 2 direct reports
Get started